PAYNE JOHN BERNARD 4
4 · Zivo Bioscience, Inc. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
PAYNE JOHN BERNARD
DirectorPresident and CEO
Transactions
- Award
Nonstatutory Stock Option to Purchase Common Stock
2022-12-16+191,016→ 191,016 totalExercise: $2.86Exp: 2032-12-15→ Common Stock (191,016 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the 2021 Equity Incentive Plan and vested immediately upon grant.